Search

Your search keyword '"Kräusslich, Hans-Georg"' showing total 789 results

Search Constraints

Start Over You searched for: Author "Kräusslich, Hans-Georg" Remove constraint Author: "Kräusslich, Hans-Georg"
789 results on '"Kräusslich, Hans-Georg"'

Search Results

1. Evolution of SARS-CoV-2 in the Rhine-Neckar/Heidelberg Region 01/2021 – 07/2023

3. Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

5. Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: population-based, nested case-control study

6. Spatial resolution of HIV-1 post-entry steps in resting CD4 T cells

7. Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools - a cluster randomised trial

8. Post-COVID syndrome and work ability 9-12 months after a SARS-CoV-2 infection among over 9000 employees from the general population

13. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial

14. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling

15. Chemogenetic Control of Nanobodies

16. Live-cell observation of cytosolic HIV-1 assembly onset reveals RNA-interacting Gag oligomers

17. HIV-1 Maturation

18. The phenuivirus Toscana virus makes an atypical use of vacuolar acidity to enter host cells

19. An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data

20. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial

27. Scalable RT‐LAMP‐based SARS‐CoV‐2 testing for infection surveillance with applications in pandemic preparedness

28. Live‐virus neutralization of the omicron variant in children and adults 14 months after SARS‐CoV‐2 wild‐type infection

31. Antiviral Strategies

33. Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

34. 1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial

35. Waning Immunity 14 Months After SARS-CoV-2 Infection

38. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study

43. Antiviral Drugs

50. Long COVID Symptoms in a Prospective Cohort of Exposed and Infected Children and Adolescents and Their Parents One Year After SARS-CoV-2 Infection

Catalog

Books, media, physical & digital resources